Pioglitazone

Back to search

Molecule Structure

Scientific Name

Pioglitazone

Description of the Drug

Pioglitazone is a thiazolidinedione used adjunctively with diet and exercise to normalize glycemic levels in adults with type 2 diabetes mellitus.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01132

Brand Name(s)

Not Available

Company Owner(s)

Nostrum Laboratories Inc, Hainan Shuangcheng Pharmaceuticals Co Ltd, Takeda Pharmaceuticals Usa Inc, Sandoz Inc, Celltrion Inc, Macleods Pharmaceuticals Ltd, Picket Pharmaceuticals Inc, Annora Pharma Private Ltd, Accord Healthcare Inc, Aurobindo Pharma Ltd

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Peroxisome proliferator-activated receptor gamma SINGLE PROTEIN AGONIST CHEMBL235

Unichem Links

Atlas pioglitazone
SureChEMBL SCHEMBL4121
PharmGKB PA450970
Human Metabolome Database HMDB0015264
DrugBank DB01132
PubChem: Thomson Pharma 14828061
PubChem 4829
Mcule MCULE-2346786634
LINCS LSM-1592
Nikkaji J277.717G
BindingDB 50103521
EPA CompTox Dashboard DTXSID3037129
DrugCentral 2179
Brenda 6203 83443
ChemicalBook CB71177472
Guide to Pharmacology 2694
rxnorm DUETACT PIOGLITAZONE HYDROCHLORIDE PIOGLITAZONE ACTOS
PubChem: Drugs of the Future 22395182
KEGG Ligand C07675
ChEBI 8228